AIIMS Delhi introduces free drug monitoring tests for epilepsy patients

Written By :  Kajal Rajput
Published On 2026-01-08 04:00 GMT   |   Update On 2026-01-08 04:00 GMT

AIIMS

Advertisement

New Delhi: The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy from January 1, significantly reducing the need for testing at private laboratories, the institute said.

Epilepsy is a chronic brain disorder causing recurrent seizures, which are sudden bursts of abnormal electrical activity, leading to symptoms like muscle jerking, confusion, loss of awareness, or psychological changes.

Advertisement

In a statement, AIIMS explained that the drug monitoring test will measure the concentration of specific medications in a patient’s blood. This will ensure the dosage is both safe and effective, news agency IANS reported.

Also Read:AIIMS expert warns of rising mental health disorders among children

Epilepsy patients are prescribed several medications, and AIIMS has decided to provide free testing facilities for monitoring phenobarbital, carbamazepine, valproic acid, and phenytoin,” the statement said.

“The therapeutic drug monitoring tests are conducted to measure the levels of these drugs in the blood. This allows for the evaluation of the drug’s effectiveness and helps in determining the appropriate dosage. This test also checks for any potential drug toxicity,” it added.

The institute noted that with the new facility, patients will no longer need to go outside for testing and will not have to pay any fees. Earlier, patients were required to spend between Rs 390 and Rs 1,880 for therapeutic drug monitoring tests for different medications at outside facilities.

In a circular dated January 1, undersigned by Prof. Nirupam Madaan, Medical Superintendent, the AIIMS administration issued instructions to all departments and centres, including the National Cancer Institute (NCI), to send patient samples to the designated laboratory for testing, reports IANS.

Both inpatients and outpatients can avail of this testing facility, the institute said.

The service will be available to AIIMS Delhi OPD patients at Collection Centre Room Number 3 from 8:30 AM to 1:00 PM, and also at the National Cancer Institute at AIIMS Jhajjar.

Also Read:AIIMS doctor refutes Pooja Makhija's salt claims, warns against oversimplifying emergency care

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News